Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa E Ibrahim

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
AIDS Research and Human Retroviruses|April 29, 2021
<i>Letter to the Editor:</i> Revisiting the Pharmacological Forgiveness of HIV Pre-Exposure ProphylaxisMustafa E Ibrahim, David V Glidden, Robert M Grant, et al.
AIDS Research and Human Retroviruses|November 16, 2020
Individualized Adherence Benchmarks for HIV Pre-Exposure ProphylaxisMustafa E Ibrahim, Jose R Castillo-Mancilla, Jenna Yager, et al.
AIDS Research and Human Retroviruses|July 27, 2018
Short Communication: Bioequivalence of Tenofovir and Emtricitabine After Coencapsulation with the Proteus Ingestible SensorMustafa E Ibrahim, Kristina M Brooks, José R Castillo-Mancilla, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 14, 2021
Approaches to handling missing or "problematic" pharmacology data: PharmacokineticsDonald J Irby, Mustafa E Ibrahim, Anees M Dauki, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 17, 2020
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS StudyJenna Yager, Jose Castillo-Mancilla, Mustafa E Ibrahim, et al.
European Journal of Clinical Pharmacology|September 17, 2018
Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patientsMustafa E Ibrahim, Cara Chang, Yichun Hu, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2019
Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarateKristina M Brooks, Mustafa E Ibrahim, Jose R Castillo-Mancilla, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2020
Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvirKristina M Brooks, Jose R Castillo-Mancilla, Mary Morrow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2020
Tenofovir Diphosphate Concentrations in Dried Blood Spots From Pregnant and Postpartum Adolescent and Young Women Receiving Daily Observed Pre-exposure Prophylaxis in Sub-Saharan AfricaLynda Stranix-Chibanda, Peter L Anderson, Deborah Kacanek, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
AIDS Research and Human Retroviruses|April 29, 2021
<i>Letter to the Editor:</i> Revisiting the Pharmacological Forgiveness of HIV Pre-Exposure ProphylaxisMustafa E Ibrahim, David V Glidden, Robert M Grant, et al.
AIDS Research and Human Retroviruses|November 16, 2020
Individualized Adherence Benchmarks for HIV Pre-Exposure ProphylaxisMustafa E Ibrahim, Jose R Castillo-Mancilla, Jenna Yager, et al.
AIDS Research and Human Retroviruses|July 27, 2018
Short Communication: Bioequivalence of Tenofovir and Emtricitabine After Coencapsulation with the Proteus Ingestible SensorMustafa E Ibrahim, Kristina M Brooks, José R Castillo-Mancilla, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 14, 2021
Approaches to handling missing or "problematic" pharmacology data: PharmacokineticsDonald J Irby, Mustafa E Ibrahim, Anees M Dauki, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 17, 2020
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS StudyJenna Yager, Jose Castillo-Mancilla, Mustafa E Ibrahim, et al.
European Journal of Clinical Pharmacology|September 17, 2018
Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patientsMustafa E Ibrahim, Cara Chang, Yichun Hu, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2019
Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarateKristina M Brooks, Mustafa E Ibrahim, Jose R Castillo-Mancilla, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2020
Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvirKristina M Brooks, Jose R Castillo-Mancilla, Mary Morrow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2020
Tenofovir Diphosphate Concentrations in Dried Blood Spots From Pregnant and Postpartum Adolescent and Young Women Receiving Daily Observed Pre-exposure Prophylaxis in Sub-Saharan AfricaLynda Stranix-Chibanda, Peter L Anderson, Deborah Kacanek, et al.
Pageof 1